Literature DB >> 15675840

Highly selective deblocking of propargyl carbonates in the presence of propargyl carbamates with tetrathiomolybdate.

R Ramesh1, Ramakrishna G Bhat, Srinivasan Chandrasekaran.   

Abstract

Propargyloxycarbonyl chloride, 1, has been used to protect the hydroxyl and amino functionalities of amino alcohols and aminophenols in one pot using triethylamine or pyridine as a base. The increased reactivity of benzyltriethylammonium tetrathiomolybdate, 2, toward propargyl carbonates over propargyl carbamates is studied in detail and has been exploited further to develop an orthogonal protection strategy for the hydroxyl and amino functionalities. For example, 2-amino-1-butanol, 6a, was treated with 1 to get the N,O-diPoc compound 7a in 90% yield, which when treated with 1.1 equiv of 2 at room temperature removes the Poc group attached to oxygen while leaving the one attached to nitrogen intact to yield compound 8a in 85% yield. This particular observation offers a new protecting strategy where an amine and an alcohol group can be protected simultaneously in one pot, and in a later synthetic step, if the alcohol group has to be deprotected selectively, it can be achieved with 1 equiv of 2.

Entities:  

Year:  2005        PMID: 15675840     DOI: 10.1021/jo048777o

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Giampiero Colombano; Clara Albani; Giuliana Ottonello; Alison Ribeiro; Rita Scarpelli; Glauco Tarozzo; Jennifer Daglian; Kwang-Mook Jung; Daniele Piomelli; Tiziano Bandiera
Journal:  ChemMedChem       Date:  2014-10-22       Impact factor: 3.466

2.  Applications of propargyl esters of amino acids in solution-phase Peptide synthesis.

Authors:  Ramesh Ramapanicker; Rohit Gupta; Rajendran Megha; Srinivasan Chandrasekaran
Journal:  Int J Pept       Date:  2011-06-16

3.  Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.

Authors:  Jason T Weiss; John C Dawson; Craig Fraser; Witold Rybski; Carmen Torres-Sánchez; Mark Bradley; E Elizabeth Patton; Neil O Carragher; Asier Unciti-Broceta
Journal:  J Med Chem       Date:  2014-06-12       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.